bioRxivCancer Biology
Elevated expression of ACE2 in tumor-adjacent normal tissues of cancer patients
Abstract
The rapidly developing COVID-19 pandemic has raised a concern that cancer patients may have increased susceptibility to SARS-CoV-2 infection. This discussion has mostly focused on therapy-induced immune suppression. Here, we examined the expression patterns of ACE2, the receptor through which SARX-CoV2 enters human cells, and found that ACE2 mRNA levels are elevated in tumor-adjacent normal tissues of cancer patients, including in normal-adjacent lung tissues of lung cancer patients. These observations raise the possibility that the elevated COVID-19 risk of cancer patients may not be limited to those undergoing immune-suppressing treatment.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Colon Cancer and SARS-CoV-2: Impact of ACE2 Expression in Susceptibility to COVID-19
Mohsen Ahmadi, Salar Pashangzadeh, … Nima Rezaei·International ImmunopharmacologyPeer-reviewed·Mar 23, 2021
- Renal carcinoma is associated with increased risk of coronavirus infections
S. C. Tripathi, Vishwajit Ravavindra Deshmukh, … Ashlesh Laxman Patil·Frontiers in Molecular BiosciencesPeer-reviewed·Nov 20, 2020
- High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patients
- Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
M. E. Ortiz Bezara, A. Thurman, … D. K. Meyerholz·bioRxiv·Apr 22, 2020
- SARS-CoV-2 receptor ACE2 identifies immuno-hot tumors in breast cancer
- Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease
U. Radzikowska, M. Ding, … M. Sokolowska·bioRxiv·May 14, 2020